USFDA issues EIR for Lupin Nagpur Injectable facility Ruchika Sharma17 April 2025 3:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food...
Zydus Lifesciences announces execution of undertakings to tender over 22 lakh Amplitude Surgical shares Ruchika Sharma17 April 2025 2:00 PM ISTAhmedabad: Zydus Lifesciences Limited has announced the execution of undertakings from 7 shareholders to tender 2,236,911 Amplitude Surgical...
Intas Pharma appoints Sarang Pande as Vice President - Digital Manufacturing & Industry Automation Ruchika Sharma17 April 2025 12:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Sarang Pande as Vice President - Digital Manufacturing & Industry Automation.In...
Zydus Lifesciences venture capital arm invests in Feldan Therapeutics Ruchika Sharma17 April 2025 11:30 AM ISTPennington: Zydus Lifesciences' venture capital arm, Zynext Ventures USA LLC, has announced its investment in Feldan Therapeutics, a...
Abbott India names Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy Ruchika Sharma16 April 2025 3:35 PM ISTMumbai: Abbott India has announced the appointment of Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area...
GSK in breach for misleading prescription information on Omjjara: industry body Ruchika Sharma16 April 2025 2:34 PM ISTLondon: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards in the marketing and...
Laurus Labs gets USFDA EIR for Atchutapuram facility Ruchika Sharma16 April 2025 11:30 AM ISTAndhra Pradesh: Laurus Labs has announced that the company has received the Establishment Inspection Report (EIR) from the United States Food...
Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune, inflammatory diseases Ruchika Sharma16 April 2025 10:30 AM ISTBoston: Boehringer Ingelheim and Cue Biopharma, Inc. have announced a strategic research collaboration and license agreement to develop and...
Bristol Myers Squibb heart disease drug fails to meet main goals in late-stage study Ruchika Sharma16 April 2025 9:30 AM ISTPrinceton: Bristol Myers Squibb has announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult...
Mankind Pharma to constitute committee to evaluate ways to integrate BSV Ruchika Sharma15 April 2025 5:17 PM ISTNew Delhi: Mankind Pharma has announced that the Board of Directors of the Company at its meeting has inter-alia, considered and approved the...
Biocon Biologics secures market entry date for ophthalmology drug Yesafili in US Ruchika Sharma15 April 2025 4:18 PM ISTAdditionally, Biocon Biologics secured a settlement agreement in Canada with Bayer and Regeneron Pharma for launch of YESAFILI no later than July 1,...
AstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib Ruchika Sharma15 April 2025 3:46 PM ISTBangalore: AstraZeneca Pharma India Limited has surrendered its marketing authorisation for Olaparib film-coated tablets 100mg and 150mg...
